Nextmune enters partnership with biotechnology company Angany Inc.

Nextmune has signed an agreement to develop new vaccines for allergy and atopic dermatitis together with Angany, a...

Read more

Revisit Veterinary Dermatology Webinars from Nextmune Education Week!

A month ago, as part of our Nextmune Academy initiative to share knowledge through educational events, we held the...

Read more

Dr. Thierry Olivry's Point of View | March 2021

Sublingual immunotherapy also works in allergic cats! Dear Colleagues,...

Read more

Education Week, a huge success!

Nextmune Academy is official! We had a great kick off event in the first week of February,  our Education Week was a...

Read more

Dr. Thierry Olivry's Point of View | February 2021

Does oclacitinib predispose dogs to develop cancer? Dear Colleagues,...

Read more

Artuvet is now Nextmune!

The big moment is here… Artuvet is now NEXTMUNE And with a new name, a new logo, a new website, and much more to come!  ...

Read more

Dr. Thierry Olivry's Point of View | January 2021

What should I choose: intradermal testing or IgE serology? Dear Colleagues,...

Read more

Dr. Thierry Olivry's Point of View | December 2020

Continuing allergen immunotherapy for longer than one year should lead to a higher treatment success! To ensure the...

Read more
No posts
All posts